Schwarcz R - Search Results

1

Increased cortical kynurenate content in schizophrenia.

Schwarcz R, Rassoulpour A, Wu HQ, Medoff D, Tamminga CA, Roberts RC. Schwarcz R, et al. Biol Psychiatry. 2001 Oct 1;50(7):521-30. doi: 10.1016/s0006-3223(01)01078-2. Biol Psychiatry. 2001. PMID: 11600105

2

Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.

Sathyasaikumar KV, Stachowski EK, Wonodi I, Roberts RC, Rassoulpour A, McMahon RP, Schwarcz R. Sathyasaikumar KV, et al. Among authors: schwarcz r. Schizophr Bull. 2011 Nov;37(6):1147-56. doi: 10.1093/schbul/sbq112. Epub 2010 Oct 29. Schizophr Bull. 2011. PMID: 21036897 Free PMC article.

3

Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat.

Rassoulpour A, Wu HQ, Albuquerque EX, Schwarcz R. Rassoulpour A, et al. Among authors: schwarcz r. Neuropsychopharmacology. 2005 Apr;30(4):697-704. doi: 10.1038/sj.npp.1300583. Neuropsychopharmacology. 2005. PMID: 15496939

4

Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.

Wu HQ, Rassoulpour A, Goodman JH, Scharfman HE, Bertram EH, Schwarcz R. Wu HQ, et al. Among authors: schwarcz r. Epilepsia. 2005 Jul;46(7):1010-6. doi: 10.1111/j.1528-1167.2005.67404.x. Epilepsia. 2005. PMID: 16026552 Free article.

5

Dopaminergic control of kynurenate levels and N-methyl-D-aspartate toxicity in the developing rat striatum.

Poeggeler B, Rassoulpour A, Guidetti P, Wu HQ, Schwarcz R. Poeggeler B, et al. Among authors: schwarcz r. Dev Neurosci. 1998;20(2-3):146-53. doi: 10.1159/000017309. Dev Neurosci. 1998. PMID: 9691189

6

Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain.

Rassoulpour A, Wu HQ, Poeggeler B, Schwarcz R. Rassoulpour A, et al. Among authors: schwarcz r. Brain Res. 1998 Aug 17;802(1-2):111-8. doi: 10.1016/s0006-8993(98)00577-0. Brain Res. 1998. PMID: 9748528

7

Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus.

Wu HQ, Lee SC, Schwarcz R. Wu HQ, et al. Among authors: schwarcz r. Eur J Pharmacol. 2000 Mar 3;390(3):267-74. doi: 10.1016/s0014-2999(00)00024-8. Eur J Pharmacol. 2000. PMID: 10708733

8

Modulation and function of kynurenic acid in the immature rat brain.

Schwarcz R, Ceresoli-Borroni G, Wu HQ, Rassoulpour A, Poeggeler B, Hodgkins PS, Guidetti P. Schwarcz R, et al. Adv Exp Med Biol. 1999;467:113-23. doi: 10.1007/978-1-4615-4709-9_17. Adv Exp Med Biol. 1999. PMID: 10721048

9

Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum.

Wu HQ, Rassoulpour A, Schwarcz R. Wu HQ, et al. Among authors: schwarcz r. J Neural Transm (Vienna). 2002 Mar;109(3):239-49. doi: 10.1007/s007020200020. J Neural Transm (Vienna). 2002. PMID: 11956948

10

Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.

Ceresoli-Borroni G, Rassoulpour A, Wu HQ, Guidetti P, Schwarcz R. Ceresoli-Borroni G, et al. Among authors: schwarcz r. J Neural Transm (Vienna). 2006 Oct;113(10):1355-65. doi: 10.1007/s00702-005-0432-z. Epub 2006 Feb 9. J Neural Transm (Vienna). 2006. PMID: 16465454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

407 results

Search Page

Filters